Objective: Angiosarcoma is an aggressive malignancy with endothelial differentiation and
notoriously poor prognosis despite aggressive therapy. Limited data are available to guide …

PURPOSE Angiosarcoma is a rare vascular malignancy, and there are few published data
to guide chemotherapy treatment decisions. We present a retrospective analysis of …

Background Angiosarcomas are an uncommon type of malignancy that are generally
thought to behave usually in a locally aggressive fashion; they often metastasize to distant …

BACKGROUND Angiosarcomas (AS) are rare, aggressive tumors. Optimal treatment has not
been well defined. The authors undertook a retrospective review of patients seen at their …

Background: Angiosarcomas (AS) are rare tumors of vascular origin with a variable behavior
and overall poor prognosis. We sought to assess the outcomes of patients treated for …

Background Angiosarcoma (AS) is a rare soft tissue sarcoma with an enhanced propensity
for local and systemic failure. The outcome of locally recurrent and metastatic AS treated at a …

Angiosarcoma is a rare soft tissue sarcoma, and the data about its clinicopathological
features and prognostic factors are limited. The purpose of the present study was to report a …

We propose a literature review of available data on angiosarcoma (AS). AS account for 1%
of adult soft tissue sarcoma. Two risk factors are well-establish chronic lymhoedema …

Angiosarcoma is a highly malignancy of endothelial tumor and represents 1-2% of all soft
tissue sarcomas in humans. The aetiology of angiosarcoma is not clear but there are definite …

Background Angiosarcomas are rare, heterogeneous and a retrospective study was
conducted to describe their natural history. Patients and methods We reviewed 161 files of …